Abstract:Major depressive disorder (MDD) is a serious mental disorder with unclear pathogenesis. ProBDNF is a precursor protein of brain derived neurotrophic factor (BDNF) expressed in the central nervous system and peripheral tissues. Previous studies showed that blood proBDNF levels in MDD were increased. However, the relationship between proBDNF/p75NTR and inflammatory cytokines in peripheral blood of MDD is unknown. The current study examined the expression of proBDNF and inflammatory markers in patients with major depression. Peripheral blood mononuclear cells (PBMCs) and serum were obtained from depressive patients (n = 32) and normal donors (n = 20). We examined the mRNA and protein expression of proBDNF/p75NTR/sortilin signaling pathway, as well as tumor necrosis factor α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-10 (IL-10) in human PBMCs. The Enzyme-Linked Immunosorbent Assay (ELISA) levels of these factors in the sera were also examined. Furthermore, the correlations between each factor and severity of major depression were tested. Of biomarkers studies, we found that proBDNF, p75NTR and sortilin production were significantly increased in PBMCs from MDD patients compared with that from the normal donors. The upregulation of p75NTR in PBMCs was most obvious as determined by qPRC and Western blots. Interestingly, the expression of proBDNF/p75NTR/sortilin signaling pathway in PBMC could be reversed after therapeutic management. Inflammatory cytokines in PBMC from MDD patients were also increased. Consistently, ELISA showed that the levels of p75NTR, sortilin, IL-1β and IL-10 in the serum of major depression were also increased compared with normal donors, and positively correlated with the major depression scores. The levels of IL-1β and IL-10 were also positively correlated with the major depression scores. Intriguingly, the levels of sortilin was positively correlated with IL-1β. Further flow cytometry studies showed that the number of proBDNF and p75NTR positive CD4 + , CD8 + T cells and CD19 + B cells from MDD patients was increased and subsequently reversed after therapeutic management. The findings suggest that the upregulation of proBDNF/p75NTR/sortilin signaling pathway may relate to inflammatory markers in patients with major depression. Our data also suggest that proBDNF/p75NTR/sortilin signaling pathway may serve as biomarkers for MDD.

Serum levels of interleukin-33 and mesencephalic astrocyte derived neurotrophic factors in patients with major depressive disorder: a cross-sectional comparative design

Linking peripheral IL-6, IL-1 and hypocretin-1 with cognitive impairment from major depression

Evaluation of serum interleukin-12 and interleukin-4 as potential biomarkers for the diagnosis of major depressive disorder

Serum Interleukin Levels and Insulin Resistance in Major Depressive Disorder

Changes in the Serum Levels of Inflammatory Cytokines in Antidepressant Drug-Naïve Patients with Major Depression

Association between inflammatory cytokines and symptoms of major depressive disorder in adults

Elevated serum levels of malondialdehyde and cortisol are associated with major depressive disorder: A case-control study

Elevated Plasma Levels of Mature Brain-Derived Neurotrophic Factor in Major Depressive Disorder Patients with Higher Suicidal Ideation

Evaluation of serum MIP-1β and MCP-2 levels in major depressive disorder: A case-control study

The role of IL-33 in depression: a systematic review and meta-analysis

Detection of Proinflammatory Cytokines in Serum Samples from Patients with Primary Major Depressive Disorder

Serum Ghrelin and Leptin Concentrations in Patients with Major Depressive Disorder before and after Supplementation with Vitamin D3

Major depressive disorder, neuroticism, suicidal behaviors, and depression severity are associated with cytokine networks and their intricate interactions with metabolic syndrome

Serum NLRP3 Inflammasome and BDNF: Potential Biomarkers Differentiating Reactive and Endogenous Depression

Increased expression of ER stress, inflammasome activation, and mitochondrial biogenesis-related genes in peripheral blood mononuclear cells in major depressive disorder

Comparisons of Serum Interleukin-8 Levels in Major Depressive Patients With Drug-Free Versus SSRIs Versus Healthy Controls

The Relationship between Level of BDNF in Serum and Depressive Symptoms and Cognitive Dysfunction of Patients with Major Depression

Cognitive functions and serum levels of brain-derived neurotrophic factor in patients with major depressive disorder

Association Between Increased Serum Interleukin-8 Levels and Improved Cognition in Major Depressive Patients with SSRIs

Correlations Between Probdnf/p75ntr and Inflammatory Markers in Patients with Major Depression

Levels of serum interleukin (IL)-6, IL-1β, tumour necrosis factor-α and leptin and their correlation in depression